These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 16876224

  • 1. Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques.
    Kumar R, Orsoni S, Norman L, Verma AS, Tirado G, Giavedoni LD, Staprans S, Miller GM, Buch SJ, Kumar A.
    Virology; 2006 Oct 10; 354(1):192-206. PubMed ID: 16876224
    [Abstract] [Full Text] [Related]

  • 2. Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques.
    Noel RJ, Kumar A.
    Virology; 2006 Mar 01; 346(1):127-38. PubMed ID: 16313937
    [Abstract] [Full Text] [Related]

  • 3. Infected macaques that controlled replication of SIVmac or nonpathogenic SHIV developed sterilizing resistance against pathogenic SHIV(KU-1).
    Stephens EB, Joag SV, Atkinson B, Sahni M, Li Z, Foresman L, Adany I, Narayan O.
    Virology; 1997 Aug 04; 234(2):328-39. PubMed ID: 9268165
    [Abstract] [Full Text] [Related]

  • 4. Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques.
    Liu ZQ, Muhkerjee S, Sahni M, McCormick-Davis C, Leung K, Li Z, Gattone VH, Tian C, Doms RW, Hoffman TL, Raghavan R, Narayan O, Stephens EB.
    Virology; 1999 Aug 01; 260(2):295-307. PubMed ID: 10417264
    [Abstract] [Full Text] [Related]

  • 5. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A, Lifson JD, Li Z, Jia F, Mukherjee S, Adany I, Liu Z, Piatak M, Sheffer D, McClure HM, Narayan O.
    Virology; 2001 Jan 05; 279(1):241-56. PubMed ID: 11145906
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques.
    Luciw PA, Mandell CP, Himathongkham S, Li J, Low TA, Schmidt KA, Shaw KE, Cheng-Mayer C.
    Virology; 1999 Oct 10; 263(1):112-27. PubMed ID: 10544087
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus.
    Kumar R, Torres C, Yamamura Y, Rodriguez I, Martinez M, Staprans S, Donahoe RM, Kraiselburd E, Stephens EB, Kumar A.
    J Virol; 2004 Oct 10; 78(20):11425-8. PubMed ID: 15452267
    [Abstract] [Full Text] [Related]

  • 11. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
    Reimann KA, Watson A, Dailey PJ, Lin W, Lord CI, Steenbeke TD, Parker RA, Axthelm MK, Karlsson GB.
    Virology; 1999 Mar 30; 256(1):15-21. PubMed ID: 10087222
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T-cell immune response.
    Boyer JD, Kumar S, Robinson T, Parkinson R, Wu L, Lewis M, Weiner DB.
    J Med Primatol; 2006 Aug 30; 35(4-5):202-9. PubMed ID: 16872283
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
    Miyake A, Akagi T, Enose Y, Ueno M, Kawamura M, Horiuchi R, Hiraishi K, Adachi M, Serizawa T, Narayan O, Akashi M, Baba M, Hayami M.
    J Med Virol; 2004 Jul 30; 73(3):368-77. PubMed ID: 15170630
    [Abstract] [Full Text] [Related]

  • 18. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
    Suh YS, Park KS, Sauermann U, Kim KS, Ahn SS, Franz M, Schulte R, Wilfingseder D, Stoiber H, Uberla K, Hunsmann G, Stahl-Hennig C, Sung YC.
    Vaccine; 2008 Dec 02; 26(51):6690-8. PubMed ID: 18694796
    [Abstract] [Full Text] [Related]

  • 19. Induction of long-term protective effects against heterologous challenge in SIVhu-infected macaques.
    Villinger F, Switzer WM, Parekh BS, Otten RA, Adams D, Shanmugam V, Bostik P, Mayne AE, Chikkala NF, McClure HM, Novembre F, Yao Q, Heneine W, Folks TM, Ansari AA.
    Virology; 2000 Dec 05; 278(1):194-206. PubMed ID: 11112494
    [Abstract] [Full Text] [Related]

  • 20. Development of virus-specific immune responses in SHIV(KU)-infected macaques treated with PMPA.
    Kumar A, Buch S, Foresman L, Bischofberger N, Lifson JD, Narayan O.
    Virology; 2001 Jan 05; 279(1):97-108. PubMed ID: 11145893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.